Literature DB >> 7677983

Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes.

C Caulín1, C Bauluz, A Gandarillas, A Cano, M Quintanilla.   

Abstract

We have studied in this report the expression of keratins in mouse epidermal keratinocytes transformed in culture by a chemical carcinogen (PDV) and in cell lines (PDVCM1, PDVCM2, PDVCV1, and PDVC57) derived by tumor transplantation of PDV cells in syngeneic C57Bl/6 mice. PDV, PDVCM1, PDVCM2, and PDVCV1 cell lines are weakly to moderately tumorigenic, giving rise to squamous cell carcinomas, although not at all injection points, whereas PDVC57 cells are more malignant, inducing highly anaplastic carcinomas at 100% of injection sites. All the cell lines synthesize anomalously simple epithelial keratins, substantial amounts of K8, and minor quantities of K18 and K19, but the level of expression is increased in PDVC57. We have found that in PDVC57 cells upregulation of K8 is linked to down-regulation of the normal keratins produced by epidermal keratinocytes in culture (i.e., K5, K6, K14, and K17). On the other hand, K8 does not generally colocalize with K13, a keratin also aberrantly expressed by epidermal cell cultures when induced to differentiate by high Ca2+ medium. K13, normally synthesized in internal stratified epithelia, is anomalously induced in mouse epidermal tumors and has been used as an early marker of carcinoma progression. In tumors induced by the cell lines upon injection in mice, K8 is found in the less differentiated regions as opposite to K13, restricted to the differentiating areas of the tumors. In PDV, PDVCM1, PDVCM2, and PDVCV1 carcinomas the overall expression of K13 is higher than that of K8. However, this relation is inverted in tumors induced by PDVC57 cells, in a good correlation with the tumoral phenotypes produced by the cell lines. Our results suggest that upregulation of the simple epithelial keratin K8, as found in transformed epidermal cell lines and tumors, is a late marker of malignant progression and is associated with the loss of the differentiated phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7677983     DOI: 10.1006/excr.1993.1003

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

1.  E-cadherin controls adherens junctions in the epidermis and the renewal of hair follicles.

Authors:  Peter Young; Oreda Boussadia; Hartmut Halfter; Richard Grose; Philipp Berger; Dino P Leone; Horst Robenek; Patrick Charnay; Rolf Kemler; Ueli Suter
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

Review 2.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

3.  Loss of Snail2 favors skin tumor progression by promoting the recruitment of myeloid progenitors.

Authors:  Ana Villarejo; Patricia Molina-Ortiz; Yenny Montenegro; Gema Moreno-Bueno; Saleta Morales; Vanesa Santos; Tom Gridley; Mirna A Pérez-Moreno; Héctor Peinado; Francisco Portillo; Carmela Calés; Amparo Cano
Journal:  Carcinogenesis       Date:  2015-03-16       Impact factor: 4.944

4.  Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles.

Authors:  Jamie K Hu; Hee-Won Suh; Munibah Qureshi; Julia M Lewis; Sharon Yaqoob; Zoe M Moscato; Sofia Griff; Alison K Lee; Emily S Yin; W Mark Saltzman; Michael Girardi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

5.  Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8.

Authors:  M L Casanova; A Bravo; A Ramírez; G Morreale de Escobar; F Were; G Merlino; M Vidal; J L Jorcano
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

6.  Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway.

Authors:  R Pankov; A Umezawa; R Maki; C J Der; C A Hauser; R G Oshima
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.

Authors:  Erika L Abel; Joe M Angel; Kaoru Kiguchi; John DiGiovanni
Journal:  Nat Protoc       Date:  2009-08-27       Impact factor: 13.491

8.  COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors.

Authors:  Helena Escuin-Ordinas; Mohammad Atefi; Yong Fu; Ashley Cass; Charles Ng; Rong Rong Huang; Sharona Yashar; Begonya Comin-Anduix; Earl Avramis; Alistair J Cochran; Richard Marais; Roger S Lo; Thomas G Graeber; Harvey R Herschman; Antoni Ribas
Journal:  Mol Oncol       Date:  2013-12-01       Impact factor: 6.603

9.  Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation.

Authors:  Casey Trimmer; Gloria Bonuccelli; Sanjay Katiyar; Federica Sotgia; Richard G Pestell; Michael P Lisanti; Franco Capozza
Journal:  Am J Pathol       Date:  2012-12-22       Impact factor: 4.307

10.  Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness.

Authors:  Gaëlle Lapouge; Benjamin Beck; Dany Nassar; Christine Dubois; Sophie Dekoninck; Cédric Blanpain
Journal:  EMBO J       Date:  2012-11-27       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.